RGC
Regencell Bioscience Holdings Limited- Healthcare
- Drug Manufacturers - Specialty & Generic
- $2.79B market cap
Forecast run · Sep 14, 2026Upside rank 26 of 3,136
Model Signal
ForecastQ Daily Probabilities
86.0%
31.4%
69.1%
Analyst Consensus
Recommendation3.00/5 Hold
Last price$5.64
Price targetNo target
Analysts4
ForecastQ Portfolios
RGC is not in any ForecastQ portfolio today. The model scores it with every run; the names it picked are in Portfolios.
Company Profile
Regencell Bioscience Holdings Limited is a biotechnology firm specializing in Traditional Chinese Medicine (TCM). Its core activities revolve around the research, development, and market introduction of TCM solutions specifically designed to address neurocognitive disorders and related degeneration. The company places a particular emphasis on conditions such as attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). Established in 2014, Regencell Bioscience maintains its primary office in Causeway Bay, Hong Kong.